Penelitian Terapi Berbasis Sel Perkembangan Baru dalam Immunoterapi dan Gen Theraphy
DOI:
https://doi.org/10.61132/jucapenbi.v2i1.152Keywords:
Cell-based therapy, gene therapy, immunotherapyAbstract
Research into cell-based therapies has grown rapidly in recent years, particularly in the context of immunotherapy and gene therapy. Cell-based therapy is an innovative approach that uses living cells, such as genetically modified T cells, to recognize and destroy cancer cells or other diseases. Additionally, developments in gene therapy allow scientists to edit or repair damaged genes, thereby restoring normal cell function. This research aims to explore recent developments in cell-based therapies, as well as their impact on immunotherapy and gene therapy. The main focus is on methods used to modify cells, such as CRISPR/Cas9 technology, as well as techniques to improve the ability of immune cells to target and kill cancer cells. The research also covers the challenges faced in this therapy, including the risk of side effects, genetic stability, and sustainability of transplanted cells. The research results show that cell-based therapies offer new hope in the treatment of difficult-to-treat diseases, such as cancer and rare genetic disorders. However, further research is still needed to ensure its long-term safety and effectiveness. This research is expected to provide in-depth insight into the potential and challenges of cell-based therapies, as well as providing a basis for future clinical development.
References
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., & Rosenberg, S. A. (2002). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. Journal of Clinical Oncology, 20(18), 2913–2924. https://doi.org/10.1200/JCO.2002.10.152
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018). CAR T cell immunotherapy for human cancer. Science, 359(6382), 1361–1365. https://doi.org/10.1126/science.aar6711
Mack, M., & Riethmüller, G. (2015). BiTE antibodies for cancer therapy. Current Opinion in Molecular Therapeutics, 11(1), 22–30.
Mehta, R. S., & Rezvani, K. (2018). Chimeric antigen receptor expressing natural killer cells for the immunotherapy of cancer. Frontiers in Immunology, 9, 283. https://doi.org/10.3389/fimmu.2018.00283
Naldini, L. (2015). Gene therapy returns to centre stage. Nature, 526(7573), 351–360. https://doi.org/10.1038/nature15818
Palucka, A. K., & Banchereau, J. (2013). Dendritic-cell-based therapeutic cancer vaccines. Immunity, 39(1), 38–48. https://doi.org/10.1016/j.immuni.2013.07.004
Rosenberg, S. A., & Restifo, N. P. (2015). Adoptive cell transfer as personalized immunotherapy for human cancer. Science, 348(6230), 62–68. https://doi.org/10.1126/science.aaa4967
Synthego Corporation. (2019). CRISPR-based gene therapy: Applications and challenges. Nature Biotechnology.
Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726–736. https://doi.org/10.1038/nri2395
Wang, L., Wang, Y., Zhao, T., & Li, X. (2021). The application of stem cell-derived immune cells in cancer immunotherapy. Frontiers in Immunology, 12, 681234. https://doi.org/10.3389/fimmu.2021.681234
